BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

653 related articles for article (PubMed ID: 17237299)

  • 1. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis.
    Gillies CL; Abrams KR; Lambert PC; Cooper NJ; Sutton AJ; Hsu RT; Khunti K
    BMJ; 2007 Feb; 334(7588):299. PubMed ID: 17237299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing the progression to type 2 diabetes mellitus in adults at high risk: a systematic review and network meta-analysis of lifestyle, pharmacological and surgical interventions.
    Stevens JW; Khunti K; Harvey R; Johnson M; Preston L; Woods HB; Davies M; Goyder E
    Diabetes Res Clin Pract; 2015 Mar; 107(3):320-31. PubMed ID: 25638454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuraminidase inhibitors for preventing and treating influenza in adults and children.
    Jefferson T; Jones MA; Doshi P; Del Mar CB; Hama R; Thompson MJ; Spencer EA; Onakpoya I; Mahtani KR; Nunan D; Howick J; Heneghan CJ
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD008965. PubMed ID: 24718923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus.
    Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
    Cochrane Database Syst Rev; 2017 May; 5(5):CD012204. PubMed ID: 28489279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lifestyle and medication interventions for the prevention or delay of type 2 diabetes mellitus in prediabetes: a systematic review of randomised controlled trials.
    Yuen A; Sugeng Y; Weiland TJ; Jelinek GA
    Aust N Z J Public Health; 2010 Apr; 34(2):172-8. PubMed ID: 23331362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
    Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD012151. PubMed ID: 27749986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interventions for preventing oral mucositis in patients with cancer receiving treatment: oral cryotherapy.
    Riley P; Glenny AM; Worthington HV; Littlewood A; Clarkson JE; McCabe MG
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD011552. PubMed ID: 26695736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network Meta-analysis of the Therapeutic Effects of Hypoglycemic Drugs and Intensive Lifestyle Modification on Impaired Glucose Tolerance.
    Zhang Y; Fu Y; Mu YM; Huang Y; Xuan J
    Clin Ther; 2021 Sep; 43(9):1524-1556. PubMed ID: 34452739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
    Madsen KS; Chi Y; Metzendorf MI; Richter B; Hemmingsen B
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD008558. PubMed ID: 31794067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus.
    Moelands SV; Lucassen PL; Akkermans RP; De Grauw WJ; Van de Laar FA
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD005061. PubMed ID: 30592787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of lifestyle interventions on glucose regulation and diabetes risk in adults with impaired glucose tolerance or prediabetes: a meta-analysis.
    Jiang Q; Li JT; Sun P; Wang LL; Sun LZ; Pang SG
    Arch Endocrinol Metab; 2022 Apr; 66(2):157-167. PubMed ID: 35289514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral anti-diabetic agents for women with established diabetes/impaired glucose tolerance or previous gestational diabetes planning pregnancy, or pregnant women with pre-existing diabetes.
    Tieu J; Coat S; Hague W; Middleton P; Shepherd E
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD007724. PubMed ID: 29045765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychological interventions to improve self-management of type 1 and type 2 diabetes: a systematic review.
    Winkley K; Upsher R; Stahl D; Pollard D; Kasera A; Brennan A; Heller S; Ismail K
    Health Technol Assess; 2020 Jun; 24(28):1-232. PubMed ID: 32568666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological strategies for preventing type 2 diabetes in patients with impaired glucose tolerance.
    Smith-Marsh D
    Drugs Today (Barc); 2013 Aug; 49(8):499-507. PubMed ID: 23977667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of lifestyle interventions in reducing diabetes incidence in patients with impaired glucose tolerance: a systematic review of randomized controlled trials.
    Yoon U; Kwok LL; Magkidis A
    Metabolism; 2013 Feb; 62(2):303-14. PubMed ID: 22959500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chinese herbal medicines for people with impaired glucose tolerance or impaired fasting blood glucose.
    Grant SJ; Bensoussan A; Chang D; Kiat H; Klupp NL; Liu JP; Li X
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006690. PubMed ID: 19821382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium-glucose cotransporter (SGLT) 2 inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus.
    Hemmingsen B; Krogh J; Metzendorf MI; Richter B
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD012106. PubMed ID: 27101360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabis-based medicines for chronic neuropathic pain in adults.
    Mücke M; Phillips T; Radbruch L; Petzke F; Häuser W
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012182. PubMed ID: 29513392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventions for preventing type 2 diabetes in adults with mental disorders in low- and middle-income countries.
    Mishu MP; Uphoff E; Aslam F; Philip S; Wright J; Tirbhowan N; Ajjan RA; Al Azdi Z; Stubbs B; Churchill R; Siddiqi N
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013281. PubMed ID: 33591592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.